Teleflex

Teleflex Days Sales Outstanding

The Days Sales Outstanding (DSO) of Teleflex (TFX) as of Oct 17, 2026 is 55.04. In the previous year, Days Sales Outstanding (DSO) was 54.42 — a change of 1.14% (higher).

Days Sales Outstanding

55.04

YoY

1.14%

Last updated:

Days Sales Outstanding (DSO) of Teleflex is 2024 55.04 . Days Sales Outstanding (DSO) of Teleflex was 2023 54.42 . It decreases by 1.14% higher compared to the previous year.

The Teleflex Days Sales Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Sales Outstanding
Date
Days Sales Outstanding
Jan 1, 2017
58.82 USD
Jan 1, 2018
54.61 USD
Jan 1, 2019
58.88 USD
Jan 1, 2020
56.84 USD
Jan 1, 2021
49.83 USD
Jan 1, 2022
53.47 USD
Jan 1, 2023
54.42 USD
Jan 1, 2024
55.04 USD
The Teleflex Days Sales Outstanding history
YEARDays Sales OutstandingYoY
55.04+1.14%
54.42+1.78%
53.47+7.29%
49.83-12.33%
56.84-3.47%
58.88+7.83%
54.61-7.17%
58.82+10.68%
53.15+0.42%
52.92-2.53%
54.30—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Teleflex Stock analysis

What does Teleflex do? Teleflex Inc. is a global company founded in 1943. The company is headquartered in Wayne, Pennsylvania, USA and operates in over 40 countries worldwide. It is a leading provider of medical devices, instruments, and accessories for various applications in clinical practice and patient care. The business model of Teleflex is based on the manufacturing and marketing of medical devices and instruments, particularly in the areas of anesthesia, vascular access, interventional medicine, pulmonary and thoracic surgery, urological care, cardiovascular diagnostics, and surgery. The company works closely with medical professionals and clinicians to develop high-quality products that meet the needs of patients and doctors. Teleflex is divided into several business segments, including angiography/diagnostics, anesthesia, oncology, vascular intervention, pulmonology, surgery, and urology. Each of these segments offers a wide range of products and solutions specifically tailored to the needs of doctors and patients. In the angiography/diagnostics segment, Teleflex offers a variety of products that can be used for the diagnosis and treatment of cardiovascular diseases and other medical conditions. These include catheters, guide wires, and sheaths. The anesthesia segment of Teleflex includes products such as ventilation bags, endotracheal tubes, and nebulizer systems. These products are essential for the successful performance of anesthesia procedures and can help doctors save valuable time and resources. The oncology segment of Teleflex offers a wide range of products specifically designed for the treatment of cancer patients. These include catheter-based systems that can facilitate the administration of drugs and other therapies. With the vascular intervention segment, Teleflex offers a comprehensive range of products and solutions specifically designed for the treatment of vascular diseases. These include balloon catheters, stents, and sheaths. The pulmonology segment of Teleflex offers products aimed at facilitating breathing and improving the quality of life for patients with chronic respiratory diseases. These include oxygen concentrators, tracheal tubes, and ventilators. The surgical segment of Teleflex offers a variety of solutions for performing surgical procedures, including surgical instruments, sutures, and wound care materials. The urology segment of Teleflex offers a wide range of products specifically designed for use in urology. These include catheters, wires, and stents. Teleflex is a leading company in the medical technology industry that specializes in the development and marketing of products that improve patients' quality of life and facilitate the work of doctors. With its innovative solutions and a focus on providing the best possible customer service and patient safety, Teleflex has taken on a significant role in the industry and will continue to be an important provider in this market in the future. Teleflex is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Teleflex stock

Days Sales Outstanding (DSO) of Teleflex is 55.04 in 2024.

Days Sales Outstanding (DSO) of Teleflex changed from 54.42 to 55.04, representing a 1.14% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Days Sales Outstanding (DSO) Teleflex since 2006 – with annual values, charts, and detailed analysis.

DSO measures the average number of days it takes to collect payment after a sale. Lower DSO indicates faster cash collection.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Sales Outstanding (DSO)'s Teleflex with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Sales Outstanding (DSO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Sales Outstanding (DSO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Teleflex

All Key Metrics — Teleflex